Speedy elimination of ureterolithiasis in lower part of ureters with the alpha 1-blocker - Tamsulosin

International Urology and Nephrology

Volumn 34, Issue 1, 2002, Pages 25-29

  Çervenàkov, Ilja ^a   Fillo, J ^a   Mardiak, J ^a   Kopecnu M ^a   Smirala J ^a   Lepies P ^a  

^a NONE   (Slovakia)

Author keywords

Alpha 1 blockers; Lower Urinary Tract Symptoms (LUTS); Receptors; Ureterolithiasis

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ANXIOLYTIC AGENT; DERMATOLOGICAL AGENT; DIAZEPAM; DICLOFENAC; ESCIN; NONSTEROID ANTIINFLAMMATORY AGENT; TAMSULOSIN; TRAMADOL; URINARY TRACT SPASMOLYTIC AGENT; YELLON;

ACUTE PYELONEPHRITIS; ADOLESCENT; ADULT; AGED; ANALGESIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CONTROL; DOUBLE BLIND PROCEDURE; DRUG POTENTIATION; DRUG TOLERABILITY; FEMALE; HUMAN; KIDNEY COLIC; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MALE; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; SMOOTH MUSCLE SPASM; STANDARD; URETER STONE; URINARY TRACT DISEASE;

ADOLESCENT; ADRENERGIC ALPHA-ANTAGONISTS; ADULT; AGED; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; REMISSION INDUCTION; SULFONAMIDES; TIME FACTORS; URETERAL CALCULI;

EID: 0036950744     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1021368325512     Document Type: Article

References (16)

1. Porpiglia F, Destefanis P, Fiori C, Fontana D. Effectiveness of nifedipine and deflazacort in the management of distal ureter stones. Urology 2000; 56: 579-583.
2. Carstensen HE, Hansen JS. Stones in the ureter. Acta Chir Scand 1973; 351: 1797-1801.
3. Hancock AA, Meyer MD, Brune, ME et al. Fiduxosin: An alfa 1 A/D receptor antagonist with enhanced in vivo uroselectivity. Relative to terazosin and tamsulosin. AUA Annual Meeting, Atlanta, Georgia, April 29-May 4, 2000.
4. Ukhal M, Malomuzh O, Strashny V. Administration of doxazosine for speedy elimination of stones from lower section of ureter. XIVth. Congress of the EUA, Stockholm, 1999, April 7-11.
5. Flam T, Saighi D, Gaél T, Denis T et al. Multiple sessions extracorporeal shock wave lithotripsy: For which stones is it worth it? XIVth Congress of the EUA, Stockholm, 1999, April 7-11.
6. Morse RM, Resnick M. Ureteral calculi: Natural history and treatment in era of advanced technology. J Urol 1991; 145: 263-265.
7. Ueno A, Kawamura T, Ogawa A, Takayasu H. Relation of spontaneous passage ureteral calculi to size. Urology 1977; 10: 544-546.
8. Hubner WA, Irby P, Stoller ML. Natural history and current concepts for the treatment of small ureteral calculi. Eur Urol 1993; 24: 172-176.
9. Marenčák J, Moro R. The therapy of ureteral stones: ESWL in situ or endoscopy? Urológia (SK) 1997; 2: 67-73.
10. Cooper JT, Stack GM, Cooper TP. Intensive Medical Management of Ureteral Calculi Urology 2000; 56: 575-578.
11. Michel MC, Bressel HU, Mehlburger L, Goepel M. Tamsulosin real life clinical experience in 19,365 patients. Eur Urol 1998; 34(2): 37-45.
12. Červenakov I, Fillo J. Our experience with the treatment of benign prostatic hyperplasia (BPH) with tamsulosin. Bratisl Iek Listy 2001; 102(2): 138-141.
13. Červenakov Mardiak J, Dimov D, Mala M, Chovan D. Antimicrobial therapy of prostatitis and prostatic syndrome in a combination with alfa 1 blocker (Tamsulosin-Omnic 0,4). Urológia (SK) 1999; 5(1): 41-45.
14. Debruyne FMJ. Alpha-blockers: Are all creater equal? Urology 2000; 56: 20-22.
15. Schwinn DA. Novel role for alpha 1-adrenergic receptor subtypes in lower urinary tract symptoms. B J U International 2000; 86, Suppl. 2: 11-22.
16. Marks LS, Curtis SP, Narayan P et al. Effects of a highly selective alpha-1 A antagonist on urinary flow rate in men with symptomatic BPH. AUA Annual Meeting 2000, Atlanta, April 29-May 4.